Lepu
Last updated October 12, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Lepu (乐普医疗) is a Chinese cardiovascular-focused healthcare group whose official website describes it as building a full cardiovascular health industry-chain platform. Its business is organized around four pillars: medical devices, pharmaceutical products, medical services and health management, and new-format medical businesses. The company positions itself around the entire lifecycle of cardiovascular care — from prevention and diagnosis to treatment and post-operative recovery. On the device side, Lepu's portfolio spans cardiovascular intervention products such as coronary stent systems (including the NeoVas bioresorbable rapamycin-eluting stent and the Nano plus polymer-free drug-eluting stent), balloon catheters, guidewires and catheters, cardiac rhythm management and electrophysiology products, structural heart disease occluders, cardiac surgery consumables, and medical equipment including angiography systems and POCT diagnostic platforms. It also offers in-vitro diagnostics, molecular diagnostics, surgical instruments, peripheral vascular and blood purification products, ultrasound imaging, and orthopedic products. On the pharmaceutical side, the website lists products such as clopidogrel bisulfate tablets, atorvastatin calcium tablets, levosimendan injection, losartan potassium hydrochlorothiazide tablets, valsartan capsules, amlodipine besylate tablets, and cefoperazone sodium and tazobactam sodium for injection. Lepu also operates medical services and health management, including cardiovascular health consultation centers, grassroots hospital cooperation, and remote ECG monitoring. Lepu has pursued digital and smart-medical directions, notably an AI-ECG Platform for automatic electrocardiogram analysis and diagnosis that the website states received U.S. FDA registration in November 2018 and EU CE certification in November 2018, and was submitted for Chinese testing in July 2018. The company also describes mobile medical, medical finance, and medical technology incubation initiatives as part of its new-format medical business. Its stated values are integrity, gratitude, respect, understanding, cooperation, and sharing.
History
Lepu's official website presents the company as having grown around a cardiovascular health industry-chain platform, with a copyright notice spanning 1999 to 2019. The company's development narrative is organized around four integrated business pillars: medical devices, pharmaceutical products, medical services and health management, and new-format medical businesses. In medical devices, Lepu built a broad cardiovascular intervention franchise. Its coronary stent line includes the Partner rapamycin-eluting stent system, described on the website as a classic first-generation choice with leading single-brand sales in China; the GuReater cobalt-chromium rapamycin-eluting stent with a biodegradable PLGA coating; the Nano plus polymer-free drug-eluting stent; and the NeoVas bioresorbable coronary rapamycin-eluting stent system. Around these, the company developed balloon catheter lines such as Vitality Mini and Vesselin drug-coated coronary balloons, Vesscide cutting balloon systems, and Hoper and Tadpole PTCA balloon catheters, as well as guidewires and catheters including ULTRASKIN and Sailor. Lepu expanded beyond coronary intervention into cardiac rhythm management and electrophysiology, structural heart disease occluders, cardiac surgery consumables, and medical equipment. Its equipment and diagnostics portfolio includes angiography systems, POCT testing platforms such as the LEPU Fluo1800 automated fluorescence analyzer, and the LeScan ultrasonic liver fibrosis detector. The website also lists in-vitro diagnostics, molecular diagnostics, surgical staplers and energy devices, peripheral vascular products, blood purification, ultrasound imaging, and orthopedic products. In pharmaceuticals, Lepu markets cardiovascular and other drugs including clopidogrel bisulfate tablets, atorvastatin calcium tablets, levosimendan injection, losartan potassium hydrochlorothiazide tablets, valsartan capsules, amlodipine besylate tablets, and cefoperazone sodium and tazobactam sodium for injection. A notable digital milestone came in 2018, when Lepu's AI-ECG Platform for automatic electrocardiogram analysis and diagnosis received U.S. FDA registration on November 19, 2018 and EU CE certification on November 5, 2018, after being submitted for testing in China in July 2018; the website describes it as China's first AI ECG product to obtain both FDA approval and CE certification. The company has also pursued mobile medical, medical finance, and medical technology incubation as part of its new-format medical business, and provides medical services including cardiovascular health consultation centers, grassroots hospital cooperation, and remote ECG monitoring.
- 2018
Lepu submitted its AI-ECG Platform for testing to the China National Institutes for Food and Drug Control under the drug regulator.
- 2018
Lepu's AI-ECG Platform obtained EU CE certification.
- 2018
Lepu's AI-ECG Platform received U.S. FDA registration approval, described by the company as China's first AI ECG product to obtain both FDA approval and CE certification.
Products and positioning
NeoVas bioresorbable coronary rapamycin-eluting stent system
A bioresorbable coronary stent system listed among Lepu's coronary stent series.
Nano plus polymer-free intravascular rapamycin-eluting stent system
A polymer-free drug-eluting coronary stent system.
Partner intravascular rapamycin-eluting stent system
Described on the website as a classic first-generation choice with leading single-brand sales in China.
GuReater cobalt-chromium rapamycin-eluting stent system
A cobalt-chromium stent with PLGA biodegradable coating and large-diameter options.
Vitality Mini drug-coated coronary balloon dilation catheter
A drug-coated coronary balloon catheter.
Vesselin drug-coated coronary balloon catheter
A drug-coated coronary balloon catheter.
Vesscide cutting balloon system
A cutting balloon system for coronary intervention.
Hoper and Tadpole PTCA balloon dilation catheters
PTCA balloon dilation catheters, with Tadpole featuring a hydrophilic coating and small-diameter options.
ULTRASKIN angiography guidewire and Sailor PTCA guidewire
Guidewires for angiography and PTCA procedures.
AI-ECG Platform
An AI-based automatic ECG analysis and diagnosis system that received FDA registration and CE certification in 2018.
LEPU Fluo1800 automated fluorescence detection analyzer
A POCT detection platform product.
LeScan ultrasonic liver fibrosis detector
An ultrasonic device for liver fibrosis detection.
Pharmaceutical products
Includes clopidogrel bisulfate tablets, atorvastatin calcium tablets, levosimendan injection, losartan potassium hydrochlorothiazide tablets, valsartan capsules, amlodipine besylate tablets, and cefoperazone sodium and tazobactam sodium for injection.
Medical services and health management
Includes cardiovascular health consultation centers, grassroots hospital cooperation, and remote ECG monitoring.
Controversies
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/lepu · Editorial policy · How profiles are compiled